It's Tuesday, April 13th.

Welcome to Marketfoolery.

I'm Chris Hill with me today, Alicia Alfieri.

Thanks for being here.

Delighted to be here.

We have a look ahead at earning season.

We're going to talk travel.

We're going to talk about the latest in the chip industry.

But real quick, Alicia, I feel like we have to start with just for a moment with the

big headline of the morning, which is Johnson and Johnson, for those who haven't heard

the news.

My administration is asking states to temporarily halt using J&J's COVID-19 vaccine after six

people in the United States developed a rare blood clotting disorder.

The FDA said, and I'm quoting here, this is out of an abundance of caution.

And when you look at the numbers, it really does seem like it's out of an abundance of

caution.

I'm not questioning the move, but look, we're a show about business and stocks.

And when you look at shares of Johnson and Johnson down 1%, 2%, it seems like at least

in this moment, keeping in mind, there's more information still to come to light.

In this moment, this doesn't seem like a huge concern for the business of Johnson and

Johnson.

Yeah.

...